Similar to primary HGSCs, in vitro therapy of these cells lines with carboplatin eliminated CA125-positive but not -negative cells, while addition of birinapant to carboplatin eliminated all tumour subpopulations (Supplementary Fig. 7a and Supplementary Data 2, n=3 replicates). The gene discussed is MUC16; the disease is neoplasm.